Kezar Life Sciences Stock (NASDAQ: KZR) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 527.01K |
Day Range | - - - |
52 Wk Range | 0.54 - 1.25 |
Market Cap | $42.35M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 1.34% |
Days to Cover | 3.11 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Kezar Life Sciences (NASDAQ:KZR) through any online brokerage.
Other companies in Kezar Life Sciences’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Estrella Immunopharma (NASDAQ:ESLA), OncoCyte (NASDAQ:OCX), Gain Therapeutics (NASDAQ:GANX) and CARISMA Therapeutics (NASDAQ:CARM).
Kezar Life Sciences has a consensus price target of $4.50.
The stock price for Kezar Life Sciences (NASDAQ: KZR) is $0.580496 last updated September 20, 2024 at 7:58 PM EDT.
There are no upcoming dividends for Kezar Life Sciences.
Kezar Life Sciences’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Kezar Life Sciences.
Kezar Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.